UBI Insider Trading Activity and SEC Form 4 Filings
UBI insider trading summary
No open-market insider purchases or sales of Universal Biosensors Inc (UBI) have been reported on SEC Form 4 in the past 12 months.
Latest UBI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 27, 2024 | Craig E. Coleman | Director | Buy | $156K (1,421,293 @ $0.11) |
| May 1, 2024 | Craig E. Coleman | Director | Buy | $33K (217,182 @ $0.15) |
| May 1, 2024 | Craig E. Coleman | Director | Buy | $4.4M (29,289,424 @ $0.15) |
| Mar 25, 2024 | Craig E. Coleman | Director | Buy | $200K (1,000,000 @ $0.20) |
| Sep 11, 2023 | Craig E. Coleman | Director | Buy | $22K (100,000 @ $0.22) |
| Jun 30, 2023 | David L Hoey | Director | Buy | $16K (95,983 @ $0.17) |
| Nov 16, 2022 | Craig E. Coleman | Director | Buy | $4K (17,848 @ $0.24) |
| Nov 15, 2022 | Craig E. Coleman | Director | Buy | $20K (82,152 @ $0.24) |
| Nov 11, 2022 | Craig E. Coleman | Director | Buy | $13K (50,000 @ $0.25) |
| Aug 17, 2022 | Craig E. Coleman | Director | Buy | $56K (200,000 @ $0.28) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.